December 12, 2006 — Health Canada has approved a pen-like device for administering adalimumab in the treatment of moderate to severe rheumatoid arthritis and psoriatic arthritis; the European ...
June 27, 2006 — The US Food and Drug Administration (FDA) has approved a pill-swallowing cup to facilitate ingestion of medications and vitamins in patients who have difficulty swallowing; an ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
ABBOTT PARK, Ill., June 26 (UPI) -- Abbott said Monday the Food and Drug Administration approved its Humira Pen, a device for administering the arthritis therapy. The pen, which has a one-touch ...
You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Patients in the US are paying a sticker price upwards of $3,000 per pen for blockbuster arthritis drug ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved a new autoinjector pen option for Cyltezo, an interchangeable biosimilar to Humira. Cyltezo ...
On May 22, 2023, Boehringer Ingelheim announced that the FDA has approved the Cyltezo Pen, a new autoinjector option for Cyltezo (adalimumab-adbm). According to a previous announcement from Boehringer ...
As widely expected by the pharmaceutical industry, seven pharmaceutical companies are releasing biosimilars of AbbVie's Humira. Boehringer Ingelheim's Cyltezo (adalimumab-adbm), an interchangeable ...
ABBOTT PARK, Ill., June 26 (UPI) -- Abbott said Monday the Food and Drug Administration approved its Humira Pen, a device for administering the arthritis therapy. The pen, which has a one-touch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results